fingolimod hydrochloride has been researched along with Experimental Mammary Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hait, NC; Katsuta, E; Lyon, DE; Nagahashi, M; Rashid, OM; Raza, A; Sturgill, JL; Takabe, K; Yan, L | 1 |
| Adams, BJ; Allegood, JC; Aoyagi, T; Huang, WC; Milstien, S; Miyazaki, H; Nagahashi, M; Rashid, OM; Spiegel, S; Takabe, K; Terracina, KP; Tsuchida, J; Wakai, T; Yamada, A | 1 |
| David, M; Huang, T; Kennedy, PC; Lynch, KR; Macdonald, TL; Mathews, TP; Peyruchaud, O; Tomsig, JL; Zhu, R | 1 |
| Baaj, Y; Cook-Moreau, J; Faucher-Durand, K; Fourcade, L; Funalot, B; Mollard, S; Mousseau, Y; Nizou, A; Plainard, X; Qiu, H; Richard, L; Sturtz, FG | 1 |
| Azuma, H; Fukui, R; Hoshiga, M; Ichimaru, N; Ishihara, T; Itoh, Y; Katsuoka, Y; Morimoto, J; Nonomura, N; Okuyama, A; Otsuki, Y; Suzuki, S; Takahara, S; Wang, JD | 1 |
5 other study(ies) available for fingolimod hydrochloride and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophospholipids; Mammary Neoplasms, Experimental; Mice; Obesity; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Retrospective Studies; Sphingosine; STAT3 Transcription Factor | 2017 |
Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.
Topics: Activation, Metabolic; Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Extracellular Fluid; Female; Fingolimod Hydrochloride; Humans; Isoenzymes; Lysophospholipids; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Prodrugs; Random Allocation; Sphingosine; Tumor Microenvironment | 2016 |
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.
Topics: Animals; Benzene Derivatives; Blotting, Western; Calcium; Capillary Permeability; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Cyclobutanes; Female; Fingolimod Hydrochloride; Guanosine 5'-O-(3-Thiotriphosphate); Lymphocyte Count; Lymphopenia; Mammary Neoplasms, Experimental; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Prodrugs; Propylene Glycols; Protein Conformation; Radioligand Assay; Receptors, Lysosphingolipid; Sphingosine; Structure-Activity Relationship | 2011 |
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma 256, Walker; Cell Movement; Cells, Cultured; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fingolimod Hydrochloride; Indoles; Male; Mammary Neoplasms, Experimental; Myocytes, Smooth Muscle; Neoplasm Transplantation; Propylene Glycols; Proto-Oncogene Proteins c-sis; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Statistics, Nonparametric; Sunitinib; Tumor Burden; Tyrphostins | 2012 |
Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.
Topics: Actins; Animals; Apoptosis; Cell Adhesion; Cell Movement; Cytoskeleton; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Integrins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Microscopy, Electron; Neoplasm Metastasis; Propylene Glycols; Sphingosine; Tumor Cells, Cultured | 2002 |